IC
ORCL icon

Inscription Capital’s Oracle ORCL Stock Holding History

Inscription Capital’s Portfolio ORCL Stock Details ORCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$678K Sell
4,609
-2,335
-34% -$380K 0.07% 278
2025
Q4 		$1.35M Buy
6,944
+2,253
+48% +$536K 0.14% 123
2025
Q3 		$1.32M Buy
4,691
+256
+6% +$65.2K 0.14% 123
2025
Q2 		$970K Sell
4,435
-4,003
-47% -$646K 0.14% 114
2025
Q1 		$1.06M Buy
+8,438
New +$1.37M 0.17% 96
2024
Q3 		$1.47M Buy
8,618
+179
+2% +$25.9K 0.22% 76
2024
Q2 		$1.19M Buy
8,439
+1
+0% +$124 0.19% 88
2024
Q1 		$1.06M Buy
8,438
+2,584
+44% +$296K 0.17% 96
2023
Q4 		$617K Buy
5,854
+486
+9% +$53K 0.17% 96
2023
Q3 		$569K Hold
5,368
– – 0.19% 89
2023
Q2 		$639K Sell
5,368
-297
-5% -$30.7K 0.2% 85
2023
Q1 		$526K Buy
5,665
+555
+11% +$48.7K 0.14% 112
2022
Q4 		$418K Hold
5,110
– – 0.14% 123
2022
Q3 		$312K Sell
5,110
-2,815
-36% -$206K 0.09% 152
2022
Q2 		$554K Buy
7,925
+3,615
+84% +$265K 0.1% 141
2022
Q1 		$357K Hold
4,310
– – 0.1% 148
2021
Q4 		$376K Hold
4,310
– – 0.1% 160
2021
Q3 		$376K Sell
4,310
-18,740
-81% -$1.66M 0.12% 149
2021
Q2 		$1.79M Buy
23,050
+18,440
+400% +$1.44M 0.2% 95
2021
Q1 		$323K Buy
4,610
+300
+7% +$19.4K 0.11% 144
2020
Q4 		$279K Sell
4,310
-200
-4% -$11.9K 0.11% 142
2020
Q3 		$269K Buy
4,510
+4
+0.1% +$227 0.12% 133
2020
Q2 		$249K Sell
4,506
-18,959
-81% -$1M 0.14% 113
2020
Q1 		$1.13M Sell
23,465
-1,760
-7% -$90.8K 0.76% 37
2019
Q4 		$1.34M Buy
25,225
+3,669
+17% +$202K 0.59% 48
2019
Q3 		$1.19M Buy
+21,556
New +$1.19M 0.65% 46

Other funds holding ORCL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Inscription Capital's ORCL Position: Q1 2026 in Review

Inscription Capital reduced its Oracle (ORCL) stake by 34% in Q1 2026, selling an estimated $380K and leaving 4,609 shares worth $678K. The position accounts for 0.07% of the portfolio, ranked #278.

Inscription Capital first reported a position in ORCL in Q3 2019 and has held it in 26 quarters since. The position peaked at $1.79M in Q2 2021. 3,475 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Inscription Capital held 4,609 shares of Oracle worth $678K as of Q1 2026.
  • Inscription Capital sold 2,335 Oracle shares in Q1 2026, an estimated $380K.
  • Oracle made up 0.07% of Inscription Capital's portfolio in Q1 2026, its #278 holding.
  • Inscription Capital first reported a position in Oracle in Q3 2019 and has held it in 26 quarters since.
  • Inscription Capital's Oracle position peaked at $1.79M in Q2 2021.
  • 3,475 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Inscription Capital's 13F filing for Q1 2026, filed 20 Apr 2026.